pemetrexed,cisplatin,gemcitabine,pembrolizumab
merck
[]
 very significant number. that's why trials data and real world data some times differs . #asco23
Oncology care , to give or not to give chemo , data analysis , oncology pharamocovigilance , enthusiastic critic, twitts are not twists